Ridgeback Capital Investments

Latest statistics and disclosures from Ridgeback Capital Investments's latest quarterly 13F-HR filing:

Ridgeback Capital Investments portfolio companies for December 2013 quarter

Ticker Name Portfolio Weight Change Share Count Price Last Trade
SGMO Sangamo Biosciences 50.91 NEW 2900000 13.89 11.91
CLDX Celldex Therapeutics 31.36 NEW 1025000 24.21 13.26
D Stemline Therapeutics 12.55 NEW 506699 19.60 0.00
Arrowhead Research 3.83 NEW 279361 10.85 0.00
GERN Geron Corporation 1.35 NEW 225000 4.74 2.44